Rathindranath C. Baral

37, S. P. Mukherjee Road
Kolkata, WB 700026, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 108 publications

Targeted Delivery of Carvacrol via TPGS-Tf-Polydopamine Nanoconjugate Scaffold on TNBC Tumor Xenograft for Understanding In Vivo Tumor Dynamics and 3D Cancer Spheroid Model, Mimicking a Tumor Environment.

Targeted Delivery of Carvacrol via TPGS-Tf-Polydopamine Nanoconjugate Scaffold on TNBC Tumor Xenograft for Understanding In Vivo Tumor Dynamics and 3D Cancer Spheroid Model, Mimicking a Tumor Environment.

Journal: Molecular pharmaceutics

Published: January 31, 2026

TPGS-Transferrin-Conjugated Carvacrol-Loaded pH-Responsive Polydopamine Nanoconjugate: A Structure-Property Interplay Emphasizing Estrogen Receptor Positive Breast Cancer Cell and Involving In Vitro and In Vivo Toxicity Assessment Studies in Experimental Models.

TPGS-Transferrin-Conjugated Carvacrol-Loaded pH-Responsive Polydopamine Nanoconjugate: A Structure-Property Interplay Emphasizing Estrogen Receptor Positive Breast Cancer Cell and Involving In Vitro and In Vivo Toxicity Assessment Studies in Experimental Models.

Journal: ACS applied bio materials

Published: December 22, 2025

Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer.

Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer.

Journal: Molecular therapy. Oncology

Published: December 17, 2025

B-cell editing: An emerging alternative of precision oncotherapy.

B-cell editing: An emerging alternative of precision oncotherapy.

Journal: Advances in immunology

Published: July 30, 2025

Notch signalling in T cells: bridging tumour immunity and intratumoral cellular crosstalk.

Notch signalling in T cells: bridging tumour immunity and intratumoral cellular crosstalk.

Journal: Frontiers in immunology

Published: July 04, 2025

Integrated profiling reveals polarity protein dysregulation during oral cancer progression.

Integrated profiling reveals polarity protein dysregulation during oral cancer progression.

Journal: Scientific reports

Published: June 23, 2025

Tumor-educated-platelets interact with breast cancer-stem-cells via P-selectin-PSGL1 and ensure stemness and metastasis through WNT-β-catenin-VEGF-VEGFR2 intra-cellular signaling: therapeutic modulation by aspirin.

Tumor-educated-platelets interact with breast cancer-stem-cells via P-selectin-PSGL1 and ensure stemness and metastasis through WNT-β-catenin-VEGF-VEGFR2 intra-cellular signaling: therapeutic modulation by aspirin.

Journal: Breast cancer research : BCR

Published: June 04, 2025

Corrigendum: The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.

Corrigendum: The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.

Journal: Frontiers in immunology

Published: July 25, 2024

Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB.

Neem leaf glycoprotein binding to Dectin-1 receptors on dendritic cell induces type-1 immunity through CARD9 mediated intracellular signal to NFκB.

Journal: Cell communication and signaling : CCS

Published: December 27, 2023

Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell-Mediated Cancer Stem Cell Aggression.

Neem Leaf Glycoprotein Disrupts Exhausted CD8+ T-Cell-Mediated Cancer Stem Cell Aggression.

Journal: Molecular cancer research : MCR

Published: November 28, 2023

The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.

The immunomodulatory impact of naturally derived neem leaf glycoprotein on the initiation progression model of 4NQO induced murine oral carcinogenesis: a preclinical study.

Journal: Frontiers in immunology

Published: October 20, 2023

High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP.

High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP.

Journal: Frontiers in immunology

Published: September 28, 2023

Showing 1-12 of 108

Last Updated: 09/26/2026